Long-Term Outcomes of Localized Prostate Cancer Survivors
Abstract
Background: Patients with localized prostate cancer face a confusing decision among many options. The standard options in current guidelines range from active surveillance, surgery, and radiation therapy (RT, various forms). Surgery and RT have evolved/improved significantly. Patients need long-term outcomes (quality of life, cancer control/recurrence, and survival) of modern treatments in order to help them make a treatment decision; however, these data do not exist. The current literature includes outcomes of older surgery and RT modalities no longer commonly used today, or short-term outcomes of modern treatments. This means that patients today do not have the information they need to make an informed decision, and must use outdated data of older prostate cancer treatments. In 2010, the study team worked with a national group of stakeholders including patients to design this study to provide data that are directly relevant to patients and stakeholders. With funding from AHRQ, PCORI and NCI, we enrolled a population-based cohort of newly-diagnosed patients, and have followed them prospectively/annually. Here, we propose to study 8-10 year outcomes.
Document Details
- Document Type
- Technical Report
- Publication Date
- Aug 01, 2021
- Accession Number
- AD1152706
Entities
People
- Aaron Katz
- Matt Nielsen
- Ronald C Chen
Organizations
- University of Kansas Medical Center
- University of North Carolina at Chapel Hill